From the Editor: NGS Gets an NCD
A growing number of studies have demonstrated that NGS offers great potential for improving diagnostic accuracy and guiding the selection of patient therapies.
Read MoreSearch Results for: genetic testing
FDA Approves First Treatment for Breast Cancer with a Certain Inherited Genetic Mutation
FDA has expanded the approved use of Lynparza to include the treatment of patients with certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation, making it the first drug in its class approved to treat breast cancer.
Read MoreIllumina, Harvard Pilgrim Expand Access to Next-Generation Sequencing for NIPT
Illumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.
Read More
BD Launches Blood Collection Tube for Cancer, Noninvasive Prenatal Testing Applications
The plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology, and was designed to ensure accurate and reproducible results in molecular diagnostic testing applications using circulating cell-free DNA.
Read More
Delivering on the Promise of NGS for Clinical Diagnostics
Presenting an evaluation of the GeneReader next-generation sequencing (NGS) system, the article assesses the performance of the system in comparison with an alternative NGS technology.
Read More